Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 1/20 | 0.63 |
| ▸ | FDPS | P14324 | 2/20 | 0.60 |
| ▸ | ACHE | P22303 | 4/20 | 0.58 |
| ▸ | BCHE | P06276 | 3/20 | 0.58 |
| ▸ | MET | P08581 | 2/20 | 0.58 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.57 |
| ▸ | APP | P05067 | 4/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.55 |
| ▸ | HPGD | P15428 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8155156 | 0.94 | TTR (0.71) | TTRFDPSMETNFE2L2APP | |
| SCHEMBL15711366 | 0.91 | FDPS (0.70) | TTRFDPSACHEBCHEMET | |
| SCHEMBL7967621 | 0.90 | TTR (0.63) | TTRFDPSACHEBCHEMET | |
| SCHEMBL7967619 | 0.90 | TTR (0.63) | TTRFDPSACHEBCHEMET | |
| SCHEMBL18270975 | 0.89 | FDPS (0.75) | TTRFDPSACHEBCHEMET | |
| SCHEMBL19358969 | 0.89 | APP (0.69) | TTRFDPSACHEBCHEMET | |
| SCHEMBL2224754 | 0.89 | APP (0.67) | TTRFDPSACHEBCHEMET | |
| SCHEMBL19358971 | 0.89 | APP (0.69) | TTRFDPSACHEBCHEMET | |
| SCHEMBL2224756 | 0.89 | APP (0.67) | TTRFDPSACHEBCHEMET | |
| SCHEMBL7252140 | 0.87 | TTR (0.60) | TTRFDPSACHEBCHEMET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8450517-B2 | Photosensitive compound and its photosensitive polymer | JNC CORPORATION (JP) | 2013-05-28 | — | — | US | disclosed |
| US-20120165491-A1 | PHOTOSENSITIVE COMPOUND AND ITS PHOTOSENSITIVE POLYMER | CHISSO PETROCHEMICAL CORPORATION (JP) | 2012-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120165491-A1 | PHOTOSENSITIVE COMPOUND AND ITS PHOTOSENSITIVE POLYMER | CCNT1, CCNA1, PYM1 | TTR 2471/4885FDPS 727/4885ACHE 4652/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.